A long-awaited assessment of potential biomarkers for detecting early ovarian cancer shows that blood levels of the CA-125 protein remain the best predictor of the disease. But if there is to be any hope that screening will reduce deaths from this disease, then more accurate markers would have to be developed, researchers concluded in the March Cancer Prevention Research. Read more > >
Communication experts from the American Cancer Society, Centers for Disease Control and Prevention, and NCI discuss how to take advantage of new communication platforms to make progress against cancer. Read more > >
President Appoints New Members to the National Cancer Advisory Board
Greenwald Named NCI Associate Director for Prevention
NCI Launches Interactive Cancer Control Community of Practice
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish .
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.